Management of atrial fibrillation in patients with heart failure.

@article{Neuberger2007ManagementOA,
  title={Management of atrial fibrillation in patients with heart failure.},
  author={H R Neuberger and Christian Mewis and Dirk J van Veldhuisen and Ulrich Schotten and Isabelle C. Van Gelder and Maurits A. Allessie and Michael B{\"o}hm},
  journal={European heart journal},
  year={2007},
  volume={28 21},
  pages={
          2568-77
        }
}
Atrial fibrillation (AF) and chronic heart failure (CHF) are two major and even growing cardiovascular conditions that often coexist. However, few data are available to guide treatment of AF in patients with CHF. This review summarizes current literature concerning the following topics: (i) prognostic relevance of AF in patients with CHF, (ii) relevance and strategies of rhythm and rate control in patients with AF and CHF, and (iii) options for prevention of AF in patients with ventricular… 
Managing patients with rapid atrial fibrillation and decompensated heart failure.
TLDR
It appears that there is no net benefit of a routine strategy to pursue sinus rhythm in patients with AF and heart failure, and the use of these therapies should be switched off.
β-Blockers in Atrial Fibrillation Patients With or Without Heart FailureCLINICAL PERSPECTIVE
TLDR
In this large nationwide cohort study, evidence of a lower mortality with β-blocker therapy in AF patients with concomitant HF was observed and indications that β- blocker treatment is also associated with a better prognosis inAF patients without conComitant HF are observed.
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions
TLDR
The current manuscript aims to review the existing literature regarding the underlying pathophysiology, to present the novel trends of treatment, and to predict the future perspective of these two linked diseases with the numerous unanswered questions.
Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time.
TLDR
Failure to CRT is associated with new-onset AF, and total atrial activation time may be a parameter to predict response in AF patients.
[Hundred years of atrial fibrillation: current knowledge and perspectives].
TLDR
There is a clear scientific proof that rhythm control offers no benefit over frequency control, at least for older patients, even with advanced left ventricular dysfunction, and optimal treatment for younger, highly symptomatic, otherwise healthy AF patients has not been designed.
Should aldosterone blockade be used beyond current indications in heart failure?
TLDR
It is hoped that the results of large randomized clinical trials further elucidate the indications of ARAs beyond current guidelines and inspire new ideas on how to best treat congestive heart failure.
Is atrial fibrillation associated with poor outcome after thrombolysis?
TLDR
Patients with AF had significantly worse 90-day clinical outcome after IVT compared to those without AF, probably due to more severe baseline neurological deficits and the greater number of arterial occlusions in the MRA before IVT.
...
1
2
3
4
...

References

SHOWING 1-10 OF 115 REFERENCES
Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.
TLDR
The present data do not support the concept that the presence, or the development of atrial fibrillation in patients with advanced chronic heart failure is independently related to an adverse outcome during long-term follow-up.
Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure
TLDR
Although CRT did not reduce the incidence of AF, CRT improved the outcome regardless of whether AF developed, and the effect of cardiac resynchronization therapy on the outcome and efficacy of CRT was evaluated.
Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.
Improving survival for patients with atrial fibrillation and advanced heart failure.
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials
TLDR
Treatment with the ACEi enalapril markedly reduces the risk of development of atrial fibrillation in patients with left ventricular dysfunction.
Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators.
TLDR
In patients with CHF, amiodarone has a significant potential to spontaneously convert patients in AF to sinus rhythm, with patients who convert having a lower mortality rate than those who do not, and the drug prevented the development of new-onset AF and significantly reduced the VR in those with persistent AF.
The Influence of Atrial Fibrillation on Prognosis in Mild to Moderate Heart Failure The V‐HeFT Studies
TLDR
Atrial fibrillation does not increase major morbidity or mortality in mild to moderate heart failure and hospitalization rate for heart failure was not increased in either study.
...
1
2
3
4
5
...